Detalhe da pesquisa
1.
Phase Ib and Expansion Study of Gemcitabine, Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer.
Oncologist;
28(5): 425-432, 2023 05 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36807743